Home
Conditions
Immunologic Deficiency Syndromes

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies

Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Increasing HAART-Induced Immune Restoration With Cyclosporine

NCT00031070

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
Locations: University of California , Davis Medical Center Sacramento, California, United States

University of Miami Miami, Florida, United States

Rush Presbyterian - Saint Luke's Med Ctr / Infect Dis Chicago, Illinois, United States

Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States

View all 15 locations

View Trial Details

Completed

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

NCT02113865

Conditions: Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus, Adenocarcinoma, +31 more
Locations: Hospital Ramón y Cajal Madrid, Spain

View Trial Details

Completed

Intervention for (Those) Recently Informed of Seropositive Status (IRISS)

NCT00720733

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: UCSF San Francisco, California, United States

View Trial Details

Completed

A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia

NCT00336245

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid

NCT00729924

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Vanderbilt Therapeutics Clinical Research Site Nashville, Tennessee, United States

View Trial Details

Completed

A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.

NCT00000391

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: Fenway Clinic Boston, Massachusetts, United States

View Trial Details

Completed

A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).

NCT00000393

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cognition Disorders, +16 more
Locations: Los Angeles County - USC Med Ctr Los Angeles, California, United States

View Trial Details

Completed

A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)

NCT00849732

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

NCT01499199

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site Providence, Rhode Island, United States

View Trial Details

Completed

Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)

NCT00632073

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Not specified

View Trial Details

Immunologic Deficiency Syndromes

Immunologic Deficiency Syndromes trial results

Related conditions